New products are live, and we’ve lowered prices across the catalog. Heads up - high demand means a 2–3 day shipping backlog. Free shipping on orders over $200!
Palm Beach Vitality

CJC/Ipamorelin Pen

$128.00

CJC (no DAC) / Ipamorelin 3 mL Pen

The Science, Simplified: This is a dual-peptide research blend combining CJC (no DAC) / Modified GRF (1-29), a tetrasubstituted GHRH analog, and Ipamorelin, a selective growth hormone secretagogue (ghrelin mimetic).

Product Specifications – CJC (no DAC) / Ipamorelin 10 mg / 10 mg 3 mL Pen

  • Total CJC (no DAC): 10 mg
  • Total Ipamorelin: 10 mg
  • Volume: 3 mL pre-filled pen
  • Concentration: ≈3.33 mg/mL CJC (no DAC) + ≈3.33 mg/mL Ipamorelin
  • Purity: Research-grade, third-party tested (COA available)
  • Format: Ready-to-use multi-dose pre-filled pen

Key Research Focus: Growth hormone release research.

Physical Form & Solubility:

  • Appearance: Clear to slightly opalescent liquid
  • Solubility: Already in aqueous solution (acetate salt form for optimal solubility and stability). Highly soluble; no reconstitution required.

Pen Format Details: The 3 mL pre-filled pen is a sterile, multi-dose delivery system designed for precise, consistent dispensing of the research blend. It features a sealed cartridge, dial-a-dose mechanism for accurate volume control, and a fine-gauge needle interface. The pen is ready for immediate laboratory use with no mixing or transfer steps required. Each pen is labeled with total peptide content and lot-specific COA reference.

Stability & Handling Notes:

  • Refrigerated at 2–8°C (36–46°F). Practical shelf life is 4–6 weeks when protected from light and handled with aseptic technique.
  • Do not freeze. Avoid prolonged room-temperature exposure.
  • Discard after 6 weeks or if the solution becomes cloudy, discolored, or shows particulate matter.
  • Protect from light and moisture at all times.

CJC-1295 / Ipamorelin Research Studies

Selected English-language peer-reviewed references for laboratory research context. Links open publisher or PubMed/PMC records.

Read the CJC-1295 / Ipamorelin research overview

  1. Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting GH releasing hormone analogPubMed 16352683
  2. Once-daily administration of CJC-1295, a long-acting growth hormone-releasing hormone (GHRH) analog, enhances GH and IGF-I secretionPubMed 16822960
  3. Activation of the GH/IGF-1 axis by CJC-1295, a long-acting GHRH analog, results in serum protein profile changesPubMed 19386527
  4. Ipamorelin, the first selective growth hormone secretagoguePubMed 9849822
  5. Efficacy of ipamorelin, a novel ghrelin mimetic, in a rodent model of postoperative ileusPubMed 19289567
CJC-1295 / Ipamorelin amino acid chain
CJC-1295 / Ipamorelin — amino acid chain (N→C)